AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
"Observational studies and clinical trials have shown conclusive evidence that periconceptional folic acid supplementation prevents up to 70% of neural tube defects (NTD). The Honduran government wanted to implement a Supplementation programme of folic acid but needed to assess the relative effects of two dosages of folic acid," scientists in the United States report (see also Clinical Trial Research).
"To determine the effect of two dosages of folic acid on blood folate levels in Honduran female factory workers aged 18 to 49 years. This was a randomized, double-blind control supplementation trial conducted in Choloma, Honduras. A total of 140 eligible women were randomly assigned to two dosage groups and followed Lip for 12 weeks. One group received a daily dosage of 1 mg folic acid and the other a once weekly dosage of 5 mg. Serum folate and red blood cell folate levels were determined by radioassay at baseline, 6 weeks and 12 weeks. Serum folate levels increased from 6.3 (SE 0.2) to 14.9 (SE 0.6) ng/ml (P
The researchers concluded: "Although both folate supplementation regimens increased serum and red blood cell folate levels significantly among the women studied, blood folate levels that are considered to be protective of NTD were reached faster with the daily dosage of 1 mg folic acid."
Rosenthal and colleagues published their study in Public Health Nutrition (Effect of different ...
Source: HighBeam Research, New clinical trial research research has been reported by J....